Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Oct 23  •  04:00PM ET
81.07
Dollar change
-0.94
Percentage change
-1.15
%
IndexS&P 500 P/E22.62 EPS (ttm)3.58 Insider Own0.15% Shs Outstand1.27B Perf Week-0.37%
Market Cap102.82B Forward P/E11.30 EPS next Y7.17 Insider Trans-66.38% Shs Float1.27B Perf Month6.14%
Enterprise Value171.50B PEG1.57 EPS next Q1.37 Inst Own87.59% Short Float1.50% Perf Quarter33.56%
Income4.53B P/S0.27 EPS this Y17.66% Inst Trans0.87% Short Ratio2.44 Perf Half Y22.98%
Sales386.46B P/B1.33 EPS next Y12.46% ROA1.77% Short Interest18.94M Perf YTD80.60%
Book/sh61.07 P/C7.23 EPS next 5Y14.43% ROE5.95% 52W High83.52 -2.93% Perf Year39.37%
Cash/sh11.21 P/FCF21.51 EPS past 3/5Y-14.99% -6.37% ROIC3.04% 52W Low43.56 86.11% Perf 3Y-11.82%
Dividend Est.2.65 (3.27%) EV/EBITDA10.55 Sales past 3/5Y8.48% 7.75% Gross Margin13.78% Volatility1.68% 2.21% Perf 5Y36.05%
Dividend TTM2.66 (3.28%) EV/Sales0.44 EPS Y/Y TTM-36.28% Oper. Margin3.01% ATR (14)1.70 Perf 10Y-20.84%
Dividend Ex-DateOct 23, 2025 Quick Ratio0.62 Sales Y/Y TTM6.27% Profit Margin1.17% RSI (14)65.28 Recom1.50
Dividend Gr. 3/5Y9.07% 5.87% Current Ratio0.80 EPS Q/Q-42.82% SMA202.92% Beta0.60 Target Price85.58
Payout72.76% Debt/Eq1.07 Sales Q/Q8.34% SMA507.84% Rel Volume0.77 Prev Close82.01
Employees300000 LT Debt/Eq0.93 EarningsOct 29 BMO SMA20022.32% Avg Volume7.76M Price81.07
IPOOct 01, 1952 Option/ShortYes / Yes EPS/Sales Surpr.24.14% 4.64% Trades Volume6,025,904 Change-1.15%
Date Action Analyst Rating Change Price Target Change
Oct-14-25Initiated Goldman Buy $91
Aug-18-25Upgrade UBS Neutral → Buy $79
Aug-14-25Upgrade Robert W. Baird Neutral → Outperform $82
Feb-13-25Upgrade Leerink Partners Market Perform → Outperform $55 → $75
Feb-12-25Upgrade Cantor Fitzgerald Neutral → Overweight
Jan-30-25Upgrade Edward Jones Hold → Buy
Dec-03-24Upgrade Deutsche Bank Hold → Buy $66
Nov-18-24Upgrade Wells Fargo Equal Weight → Overweight $60 → $66
Oct-10-24Upgrade Barclays Equal Weight → Overweight $63 → $82
Oct-04-24Upgrade TD Cowen Hold → Buy $59 → $85
Oct-23-25 05:45PM
09:40AM
06:27AM
Oct-22-25 10:00AM
09:00AM
04:15AM Loading…
04:15AM
Oct-21-25 11:40AM
10:33AM
09:15AM
Oct-20-25 06:19AM
Oct-19-25 10:16AM
Oct-17-25 05:45PM
03:14PM
10:18AM
08:37AM
09:40PM Loading…
Oct-16-25 09:40PM
07:07PM
05:09PM
01:16PM
01:10PM
10:19AM
09:50AM
09:40AM
08:50AM
03:15AM
03:01AM
02:02AM
Oct-15-25 07:48PM
03:16PM
01:52PM
12:10PM Loading…
12:10PM
11:36AM
10:54AM
10:00AM
09:41AM
09:15AM
08:31AM
08:00AM
07:10AM
Oct-14-25 09:44AM
08:58AM
08:00AM
Oct-13-25 08:44AM
08:39AM
Oct-11-25 01:33PM
10:00AM
Oct-10-25 05:45PM
Oct-09-25 05:51PM
05:24PM
09:49AM
09:30AM
09:00AM
Oct-07-25 10:00PM
12:08PM
09:40AM
09:00AM
Oct-06-25 04:15PM
Oct-03-25 11:05AM
Oct-02-25 06:18AM
Oct-01-25 05:45PM
07:00AM
Sep-30-25 02:49PM
02:21PM
10:20AM
09:00AM
Sep-25-25 10:01AM
09:50AM
09:00AM
Sep-23-25 05:45PM
10:36AM
10:31AM
08:59AM
08:23AM
Sep-22-25 01:11PM
01:01PM
10:14AM
09:35AM
07:00AM
Sep-19-25 04:00PM
09:40AM
08:46AM
Sep-18-25 04:40PM
08:37AM
Sep-17-25 05:09PM
02:07PM
12:20PM
12:12PM
11:26AM
Sep-16-25 11:01AM
Sep-15-25 05:45PM
01:48PM
05:05AM
Sep-13-25 01:49PM
Sep-12-25 05:37AM
Sep-11-25 01:01PM
11:52AM
09:00AM
08:22AM
Sep-10-25 10:29AM
09:25AM
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Finucane Anne A.DirectorAug 20 '25Sale71.027,500532,65022,156Aug 29 04:29 PM
Finucane Anne A.DirectorAug 20 '25Proposed Sale70.977,500532,275Aug 19 06:57 PM
SANSONE GUY PDirectorJun 05 '25Buy63.701,570100,00912,007Jun 09 08:22 AM
ROBBINS LARRYDirectorMay 02 '25Sale67.862,276,068154,444,7589,670,731May 06 04:15 PM
ROBBINS LARRYDirectorMay 05 '25Sale67.411,323,93289,249,9458,346,799May 06 04:15 PM
ROBBINS LARRYDirectorMay 06 '25Sale66.67150,00010,000,7108,196,799May 06 04:15 PM
Shah Prem SEVP and Group PresidentMar 17 '25Option Exercise62.2184652,63043,190Mar 18 04:51 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Option Exercise62.217,513467,38415,907Mar 07 04:56 PM
Clark James DavidSVP, Cont & Chief Acct OfficerMar 05 '25Sale66.357,513498,4888,394Mar 07 04:56 PM
Clark James DavidOfficerMar 05 '25Proposed Sale66.357,513498,489Mar 05 05:25 PM
Mahoney Michael FDirectorFeb 18 '25Buy66.7030,0002,001,00039,356Feb 19 12:35 PM